Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-21-011092
Filing Date
2021-08-10
Accepted
2021-08-10 12:03:45
Documents
65
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q tmbr-20210630x10q.htm   iXBRL 10-Q 1755088
2 EX-31.1 tmbr-20210630xex31d1.htm EX-31.1 17824
3 EX-31.2 tmbr-20210630xex31d2.htm EX-31.2 16093
4 EX-32.1 tmbr-20210630xex32d1.htm EX-32.1 7874
5 EX-32.2 tmbr-20210630xex32d2.htm EX-32.2 9381
  Complete submission text file 0001558370-21-011092.txt   7068196

Data Files

Seq Description Document Type Size
6 EX-101.SCH tmbr-20210630.xsd EX-101.SCH 58673
7 EX-101.CAL tmbr-20210630_cal.xml EX-101.CAL 53982
8 EX-101.DEF tmbr-20210630_def.xml EX-101.DEF 251523
9 EX-101.LAB tmbr-20210630_lab.xml EX-101.LAB 473535
10 EX-101.PRE tmbr-20210630_pre.xml EX-101.PRE 382268
11 EXTRACTED XBRL INSTANCE DOCUMENT tmbr-20210630x10q_htm.xml XML 1223881
Mailing Address 110 ALLEN ROAD, SUITE 401 BASKING RIDGE NJ 07920
Business Address 110 ALLEN ROAD, SUITE 401 BASKING RIDGE NJ 07920 914-205-3481
Timber Pharmaceuticals, Inc. (Filer) CIK: 0001504167 (see all company filings)

EIN.: 593843182 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37411 | Film No.: 211159090
SIC: 2834 Pharmaceutical Preparations